Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589355 · ClinicalTrials.gov registry record
C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 46
- Enrollment target
NCT00589355 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 46 participants.
The verdict
NCT00589355 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether markers of vascular inflammation (such as c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated dilation) in postmenopausal women with glucose intolerance compared to normal controls.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2002-01 |
| Est. Completion | 2008-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589355
The ClinicalTrials.gov registry entry for NCT00589355 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00589355 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00589355 about?
NCT00589355 is a clinical study titled "C-reactive Protein and Endothelial Dysfunction in Women With Glucose Intolerance". The goal of this study is to determine whether markers of vascular inflammation (such as c-reactive protein) can predict endothelial dysfunction (as measured by flow-mediated dilation) in postmenopausal women with glucose intolerance compared to normal controls.
What is the current status of trial NCT00589355?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2002-01. Estimated completion is 2008-10-01.
Who is sponsoring clinical trial NCT00589355?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.